Literature DB >> 7192555

Nucleo-cytoplasmic relationships of oestrogen receptors in rat liver during the oestrous cycle and in response to administered natural and synthetic oestrogen.

W Marr, J O White, M G Elder, L Lim.   

Abstract

Oestrogen receptors were measured in the cytosolic and purified nuclear fractions of rat liver. Both cytosolic and nuclear receptors bind oestrogen with high affinity (Kd = 1.47 and 2.28 nM respectively) and specificity similar to that of receptors in order oestrogen-target tissues such as the uterus. During the 4-day oestrous cycle the receptor content and distribution between cytosol and nucleus did not vary; in particular, the content of nuclear receptor did not appear to fluctuate in concert with known cyclic changes in the concentration of plasma oestrogen. Injection of 50 micrograms of oestradiol-17 beta or 10 micrograms of ethynyloestradiol resulted in a 4--6-fold increase in the nuclear receptor content, with a concomitant decrease in the unoccupied-receptor content of cytosol 1 h after injection. The nuclear receptors present after injection bind oestrogens with similar affinity (Kd = 2.78 nM) and specificity to receptors present in uninjected animals. The administration of lower doses of either oestrogen was less effective in producing increases in nuclear receptor content. Hence there is apparently substantial translocation of receptor to the nucleus in response to hyperphysiological doses of oestrogen, but not to the physiological changes in plasma oestrogen concentrations during the oestrous cycle. The response to exogenous oestrogens is discussed in relation to the clinical use of synthetic oestrogens and progestogens.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7192555      PMCID: PMC1162059          DOI: 10.1042/bj1900017

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  30 in total

1.  Protamine-precipitated estrogen receptor: a solid-phase ligand exchange assay.

Authors:  G C Chamness; K Huff; W L McGuire
Journal:  Steroids       Date:  1975-05       Impact factor: 2.668

2.  Effects of estrogens on renin substrate and uterine weights in rats.

Authors:  J Ménard; P Corvol; A Foliot; J P Raynaud
Journal:  Endocrinology       Date:  1973-09       Impact factor: 4.736

3.  Antithrombin 3 and the estrogen content of combined estro-progestagen contraceptives.

Authors:  J Conard; M Samama; Y Salomon
Journal:  Lancet       Date:  1972-11-25       Impact factor: 79.321

4.  Serum-lipids in women on oral contraceptives.

Authors:  T Stokes; V Wynn
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

5.  Effects of an oral contraceptive agent on plasma lipids, plasma lipoproteins, the intravenous fat tolerance and the post-heparin lipoprotein lipase activity.

Authors:  S Rössner; U Larsson-Cohn; L A Carlson; J Boberg
Journal:  Acta Med Scand       Date:  1971-10

6.  An improved method for the study of high-affinity steroid binding:-oestradiol binding in brain and pituitary.

Authors:  M Ginsburg; B D Greenstein; N J MacLusky; I D Morris; P J Thomas
Journal:  Steroids       Date:  1974-06       Impact factor: 2.668

7.  Oestrogen and nuclear binding sites. Determination of specific sites by ( 3 H)oestradiol exchange.

Authors:  J Anderson; J H Clark; E J Peck
Journal:  Biochem J       Date:  1972-02       Impact factor: 3.857

Review 8.  Hormones and the liver. The effect of estrogens, progestins, and pregnancy on hepatic function.

Authors:  C S Song; A B Rifkind; P N Gillette; A Kappas
Journal:  Am J Obstet Gynecol       Date:  1969-11-01       Impact factor: 8.661

Review 9.  The determination of nucleic acids.

Authors:  H N Munro
Journal:  Methods Biochem Anal       Date:  1966

10.  Estrogen receptor in the mammalian liver.

Authors:  A J Eisenfeld; R Aten; M Weinberger; G Haselbacher; K Halpern; L Krakoff
Journal:  Science       Date:  1976-02-27       Impact factor: 47.728

View more
  8 in total

1.  Specific adaptations of estrogen receptor alpha and beta transcripts in liver and heart after endurance training in rats.

Authors:  Amélie Paquette; Dongaho Wang; Marie-Soleil Gauthier; Denis Prud'homme; Marek Jankowski; Jolanta Gutkowska; Jean-Marc Lavoie
Journal:  Mol Cell Biochem       Date:  2007-08-01       Impact factor: 3.396

2.  Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model.

Authors:  Tiffany Brake; Paul F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

3.  Changes of gastric aromatase and portal venous 17β-estradiol during the postnatal development and estrus cycle in female rats.

Authors:  Hiroto Kobayashi; Saori Yoshida; Ying-Jie Sun; Nobuyuki Shirasawa; Akira Naito
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

4.  The effects of oestrogens and progesterone on oestrogen receptors in female rat liver.

Authors:  W Marr; M G Elder; L Lim
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

5.  The effects of 17 alpha-ethynyloestradiol and of acute inflammation on the plasma concentration of rat alpha 1-acid glycoprotein and on the induction of its hepatic mRNA.

Authors:  M Diarra-Mehrpour; J Bourguignon; I Leroux-Nicollet; D Marko-Vercaigne; D Biou; M Hiron; J P Lebreton
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

6.  17β-Estradiol in the systemic circulation derives mainly from the parietal cells in cholestatic female rats.

Authors:  H Kobayashi; S Yoshida; Y-J Sun; N Shirasawa; A Naito
Journal:  J Endocrinol Invest       Date:  2015-08-11       Impact factor: 4.256

7.  Nuclear oestrogen receptors in rat liver. Development of assay conditions, characterization and the translocation of oestrogens in vivo.

Authors:  P Tamulevicius; E R Lax; A Müller; H Schriefers
Journal:  Biochem J       Date:  1982-08-15       Impact factor: 3.857

8.  Sex steroid receptor proteins in foetal, adult and malignant human liver tissue.

Authors:  M J Iqbal; M L Wilkinson; P J Johnson; R Williams
Journal:  Br J Cancer       Date:  1983-12       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.